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ABSTRACT
Methods: A total of 60 subjects were divided into two groups of healthy (30 individuals) and metabolic syndrome patients (30 individuals) from 
dental outpatient department of Saveetha Dental College and Hospitals. 5 ml of fasting venous blood was collected in the plain collection tubes and 
centrifuged, and then serum was separated. Then, the serum was used to analyze the fasting blood glucose, serum triglycerides (TGLs), and serum 
UA by GOD-POD, enzymatic colorimetric, and uricase method, respectively. A statistical analysis was performed using Student’s t-test. p<0.05 was 
considered to be statistically significant.
Result: Mean body mass index (BMI), fasting blood sugar (FBS), TGL, and UA level of control group were 23.36±1.81, 84.45±13.1, 110.9±22.6, and 
3.48±1.21 respectively. Mean BMI, FBS, TGL, and UA level of study group were 35.24±3.04, 122.85±23.3, 212.1±39.6 and 9.08±2.63 respectively. There 
is a significant difference between these two groups with p<0.0001.
Conclusion: This study showed that those individuals with metabolic syndrome have higher UA level that indicates hyperuricemia which is a 
significant predictor of metabolic syndrome.
Keywords: Uric acid, Metabolic syndrome, Antioxidants.
INTRODUCTION
Metabolic syndrome is a cluster of risk factors that are characterized 
as having three or more of the following conditions, i.e., central obesity 
or high waist circumference (>102 cm - male and >88 cm - female), 
increased triglyceride (TGL) level (>150 mg/dl), elevated blood 
pressure (>130/90 mm of Hg), impaired fasting glucose (>100 mg/dl), 
and decreased high-density lipoprotein cholesterol (>35 mg/dl for male 
and 0.50 mg/dl for female) [1-5]. The presence of metabolic syndrome 
is strongly associated with the development of diabetes, hypertension, 
cardiovascular disease, stroke, and chronic kidney disease [6].
Uric acid (UA) is synthesized mainly in the liver, intestines, and other 
tissues such as muscles, kidneys, and vascular endothelium as the 
end product of an exogenous pool of purines, derived largely from 
animal proteins. The live and dying cells degrade their nucleic acids 
(adenine and guanine) into UA [1,7]. The main physiological function 
of UA is a strong reactive oxygen species and peroxynitrite scavenger 
and antioxidant [7-10]. UA is a powerful scavenger of free radicals 
and provides approximately 60% of free-radical scavenging capacity 
in the blood. Increased circulating level of UA indicates an adaptive 
response to protect against the excessive free radicals and oxidative 
stress [9,11,12].
Hence, the aim of the current study is to assess the level of UA in 
metabolic syndrome individuals.
METHODS
Patients were selected from those attending the outpatient department 
of Saveetha Dental College and Hospitals and divided into two groups 
as follows:
Group I - Normal healthy individuals - 30 individuals
Group II - Patients with metabolic syndrome - 30 individuals.
Inclusion criteria








The following criteria were excluded from the study:
•	 Individuals	with	 other	 systemic	 illness	 such	 as	 cardiovascular	




Informed consent was obtained from the patient before sample 
collection. 5 ml of fasting venous blood was collected and distributed 
in plain collection tubes and centrifuged in 3000 rpm for serum. Then 
serum was separated, and then, it is analyzed for FBS by GOD-POD 
method, serum TGL by colorimetric enzymatic method, serum UA by 
uricase/peroxidase method, and ERBA CHEM 5 plus analyzer.
RESULTS
All the data were analyzed using SPSS software. Student’s t-test analysis 
was performed to find significant differences between the two groups. 
All the tests were considered statistically significant at p<0.05 level.
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Objective: Metabolic syndrome is a cluster of disease condition characterized by truncal obesity, hypertriglyceridemia, elevated blood pressure, 
and insulin resistance. An excessive circulating uric acid (UA) level even within normal range is always comorbid with metabolic syndrome and 
its components. The aim of the current study was to investigate the association between metabolic syndrome and serum UA level.
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DISCUSSION
Mean BMI level in the control and study groups was 23.36±1.81 and 
35.94±3.04, respectively, (Table 1 and Fig. 1). Mean FBS level in control 
and study groups was 84.45±13.1 and 122.85±23.3, respectively 
(Table 1 and Fig. 2). Mean TGL level in control and study groups was 
110.9±22.6 and 212.1±39.6, respectively (Table 1 and Fig. 3). Mean 
UA level in control and study groups was 3.48±1.21 and 9.08±2.63, 
respectively (Table 1 and Fig. 4).
The BMI, FBS, and TGL levels in metabolic syndrome individuals were 
significantly high when compared to the healthy individuals, which 
indicate proper selection of study groups. The UA level was significantly 
high in metabolic syndrome individuals when compared to the healthy 
individuals (p=0.0001).
Our results suggest that UA level was increased in metabolic syndrome 
individuals. Metabolic syndrome is a cluster of many disease conditions 
such as diabetes mellitus, hypertension, dyslipidemia, and central 
adiposity. In all the components of metabolic syndrome, free radical 
production is increased which leads to oxidative stress and damage 
of other cells causing progression of the disease condition [13,14]. 
These processes are prevented by our body defense mechanism called 
antioxidants. There are enzymatic and non-enzymatic antioxidants. 
In non-enzymatic antioxidant, UA is a metabolic antioxidant which 
is the end product of purine metabolism. Hence, it inhibits the action 
of free radicals such as peroxyl radicals and peroxynitrite, and thus, 
it protects the cell membrane and DNA and reduces the oxidative 
stress [15]. The major pathogenesis behind the metabolic syndrome is 
insulin resistance or hyperinsulinemia [16]. Many studies suggest that 
increased UA level is due to increased absorption of the UA from the 
proximal convoluted tubules secondary to hyperinsulinemia [17,18]. 
All these factors suggested that UA level was increased in metabolic 
syndrome individuals.
CONCLUSION
This study showed that those individuals with metabolic syndrome 
have higher UA level that indicates hyperuricemia which is a significant 
predictor of metabolic syndrome. The increased UA levels reduce the 
oxidative stress and thus protect the cell membrane and DNA.
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